Eric Karas Silverback Therapeutics, Inc. (SBTX) insider trading activity

Eric Karas is Chief Commercial Officer of Silverback Therapeutics, Inc.. Currently has a direct ownership of 10,315 shares of SBTX, which is worth approximately $0. The most recent transaction as insider was on Jul 01, 2025, when has been sold 15,000 shares (Common Stock) at a price of $16.99 per share, resulting in proceeds of $254,849. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.3K

34.03% 3M change

n/a 12M change

Total Value Held $0

Eric Karas Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 01 2025	SELL Open market or private sale	$254,849 $16.99 p/Share	15,000 Reduced 59.25%	10,315 Common Stock
Jul 01 2025	BUY Exercise of conversion of derivative security	$22,500 $1.5 p/Share	15,000 Added 37.21%	25,315 Common Stock
Jun 18 2025	SELL Open market or private sale	$240,000 $16.0 p/Share	15,000 Reduced 66.09%	7,696 Common Stock
Jun 18 2025	BUY Exercise of conversion of derivative security	$22,500 $1.5 p/Share	15,000 Added 39.79%	22,696 Common Stock
Mar 20 2025	SELL Open market or private sale	$140,000 $14.0 p/Share	10,000 Reduced 56.51%	7,696 Common Stock
Mar 20 2025	BUY Exercise of conversion of derivative security	$15,000 $1.5 p/Share	10,000 Added 36.11%	17,696 Common Stock
Dec 04 2024	SELL Open market or private sale	$87,962 $14.0 p/Share	6,283 Reduced 52.46%	5,693 Common Stock
Dec 04 2024	BUY Exercise of conversion of derivative security	$9,424 $1.5 p/Share	6,283 Added 34.41%	11,976 Common Stock
Dec 02 2024	SELL Open market or private sale	$52,446 $14.11 p/Share	3,717 Reduced 39.5%	5,693 Common Stock
Dec 02 2024	BUY Exercise of conversion of derivative security	$5,575 $1.5 p/Share	3,717 Added 28.32%	9,410 Common Stock
Sep 18 2024	SELL Open market or private sale	$140,000 $14.0 p/Share	10,000 Reduced 63.72%	5,693 Common Stock
Sep 18 2024	BUY Exercise of conversion of derivative security	$15,000 $1.5 p/Share	10,000 Added 38.92%	15,693 Common Stock
Aug 19 2024	SELL Open market or private sale	$140,000 $14.0 p/Share	10,000 Reduced 63.72%	5,693 Common Stock
Aug 19 2024	BUY Exercise of conversion of derivative security	$15,000 $1.5 p/Share	10,000 Added 38.92%	15,693 Common Stock

Eric Karas

Chief Commercial Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SBTX shares.

Notify only if

Value

Insider Trading

Get notified when an Silverback Therapeutics, Inc. insider buys or sells SBTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Silverback Therapeutics, Inc.

Track Activities on SBTX

Account